IMCD N.V., through its subsidiary IMCD Italy, has signed an agreement to acquire 100% of the shares of Italian Selechimica S.R.L. This is reported in a press release from IMCD.
The deal is in line with IMCD's plans to strengthen its position in the Italian pharmaceutical market by expanding its product range and customer base.
The transaction is expected to be completed at the end of June 2024.
IMCD N.V. is a Dutch distributor of pharmaceutical products and a developer of formulations of special chemicals and ingredients. In 2023, IMCD's revenue amounted to 4.4 billion euros. The shares are traded on the Euronext Amsterdam stock exchange. The headquarters is located in Rotterdam (Netherlands).
Selechimica distributes a wide range of active pharmaceutical ingredients. The headquarters is located in Milan (Italy).
IMCD Italia SpA is a subsidiary company for the wholesale of chemicals and related products.
More news is on the Telegram channel "Mergers and Acquisitions. AK&M».
